Compare GMED & BEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMED | BEN |
|---|---|---|
| Founded | 2003 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.5B |
| IPO Year | 2012 | 2013 |
| Metric | GMED | BEN |
|---|---|---|
| Price | $81.91 | $31.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 9 |
| Target Price | ★ $100.42 | $28.56 |
| AVG Volume (30 Days) | 1.9M | ★ 4.0M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | ★ 422.67 | 7.06 |
| EPS | 0.90 | ★ 0.95 |
| Revenue | $2,938,931,000.00 | ★ $5,774,500,000.00 |
| Revenue This Year | $11.13 | N/A |
| Revenue Next Year | $6.28 | $6.07 |
| P/E Ratio | $91.91 | ★ $32.85 |
| Revenue Growth | ★ 16.65 | N/A |
| 52 Week Low | $51.79 | $21.09 |
| 52 Week High | $101.40 | $32.44 |
| Indicator | GMED | BEN |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 59.25 |
| Support Level | $74.50 | $30.54 |
| Resistance Level | $87.77 | $32.44 |
| Average True Range (ATR) | 2.59 | 0.67 |
| MACD | 0.54 | -0.23 |
| Stochastic Oscillator | 66.62 | 34.65 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.